Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00180024

Enrollment

Unknown

Registered

2005-09-16

Start date

2002-01-31

Completion date

2005-09-30

Last updated

2005-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

AT1-receptor, AT2-receptor, human pharmacology

Brief summary

The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.

Interventions

DRUGirbesartan (drug)

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

ECT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy subjects

Exclusion criteria

* any relevant disease

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026